Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease
Allison Bethanne Reiss, Isaac Teboul, Lora Kasselman, Saba Ahmed, Steven E Carsons, Joshua De Leon
DOI: 10.1136/jim-2022-002355 Published 15 August 2022
Allison Bethanne Reiss
1
Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
2
Foundations of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
Isaac Teboul
2
Foundations of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
Lora Kasselman
2
Foundations of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
Saba Ahmed
2
Foundations of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
Steven E Carsons
1
Medicine, NYU Long Island School of Medicine, Mineola, New York, USA
Joshua De Leon
1
Medicine, NYU Long Island School of Medicine, Mineola, New York, USA

Submit a Response to This Article
No eLetters have been published for this article.
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease
Allison Bethanne Reiss, Isaac Teboul, Lora Kasselman, Saba Ahmed, Steven E Carsons, Joshua De Leon
Journal of Investigative Medicine Aug 2022, 70 (6) 1433-1437; DOI: 10.1136/jim-2022-002355

Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease
Allison Bethanne Reiss, Isaac Teboul, Lora Kasselman, Saba Ahmed, Steven E Carsons, Joshua De Leon
Journal of Investigative Medicine Aug 2022, 70 (6) 1433-1437; DOI: 10.1136/jim-2022-002355
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease
Allison Bethanne Reiss, Isaac Teboul, Lora Kasselman, Saba Ahmed, Steven E Carsons, Joshua De Leon
Journal of Investigative Medicine Aug 2022, 70 (6) 1433-1437; DOI: 10.1136/jim-2022-002355